NEU 2.38% $12.70 neuren pharmaceuticals limited

End of Phase 2 Meeting with FDA - September 2024, page-4

  1. 487 Posts.
    lightbulb Created with Sketch. 56
    Don't believe NEU have yet announced lodgement of written meeting request.
    However September has been announced for meeting but no specific date.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.